Evidence map›Paper›PMID 27230854›Full record

ArticleJournal of neurology2016

XPR1 mutations are a rare cause of primary familial brain calcification.

Mathieu Anheim, Uriel López-Sánchez, Donatella Giovannini, Anne-Claire Richard, Jawida Touhami, Ludovic N'Guyen, Gabrielle Rudolf, Anne Thibault-Stoll, Thierry Frebourg, Didier Hannequin and 4 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. White Matter Matters: A Magnetic Resonance Imaging Study with Clinical Correlates in Primary Brain Calcification.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bilateral Cerebral Calcifications in Secondary Fahr's Syndrome.Case reports in neurological medicine · 2025
    Article
  14. Article
  15. Article
  16. Primary Familial Brain Calcification WithJournal of clinical neurology (Seoul, Korea) · 2024
    Article
  17. Pharmacology of Mammalian NaHandbook of experimental pharmacology · 2024
    Article
  18. Article
  19. The Genetics of Primary Familial Brain Calcification: A Literature Review.International journal of molecular sciences · 2023
    Review
  20. Brain Calcifications: Genetic, Molecular, and Clinical Aspects.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Mathieu AnheimDépartement de Neurologie, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg, France.
Uriel López-SánchezInstitut de Génétique Moléculaire de Montpellier, CNRS UMR5535, 1919 Route de Mende, 34293, Montpellier, France.
Donatella GiovanniniInstitut de Génétique Moléculaire de Montpellier, CNRS UMR5535, 1919 Route de Mende, 34293, Montpellier, France.
Anne-Claire RichardFaculté de Médecine, Inserm U1079, University of Rouen, IRIB, Normandy University, 22 Boulevard Gambetta, 76183, Rouen, France.
Jawida TouhamiInstitut de Génétique Moléculaire de Montpellier, CNRS UMR5535, 1919 Route de Mende, 34293, Montpellier, France.
Ludovic N'GuyenDépartement de Neurologie, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg, France.
Gabrielle RudolfDépartement de Neurologie, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg, France.
Anne Thibault-StollDépartement de Neurologie, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg, France.
Thierry FrebourgFaculté de Médecine, Inserm U1079, University of Rouen, IRIB, Normandy University, 22 Boulevard Gambetta, 76183, Rouen, France.
Didier HannequinFaculté de Médecine, Inserm U1079, University of Rouen, IRIB, Normandy University, 22 Boulevard Gambetta, 76183, Rouen, France.
Dominique CampionFaculté de Médecine, Inserm U1079, University of Rouen, IRIB, Normandy University, 22 Boulevard Gambetta, 76183, Rouen, France.
Jean-Luc BattiniInstitut de Génétique Moléculaire de Montpellier, CNRS UMR5535, 1919 Route de Mende, 34293, Montpellier, France. jean-luc.battini@igmm.cnrs.fr.
Marc SitbonInstitut de Génétique Moléculaire de Montpellier, CNRS UMR5535, 1919 Route de Mende, 34293, Montpellier, France. marc.sitbon@igmm.cnrs.fr.
Gaël NicolasFaculté de Médecine, Inserm U1079, University of Rouen, IRIB, Normandy University, 22 Boulevard Gambetta, 76183, Rouen, France. gaelnicolas@hotmail.com.
Université de Rouen Normandie · FRCentre National de la Recherche Scientifique · FRHôpital d'Hautepierre · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRLaboratory of Excellence GR-Ex · FRCentre Hospitalier du Rouvray · FRInserm · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in XPR1, a gene encoding an inorganic phosphate exporter, have recently been identified in patients with primary familial brain calcification (PFBC). Using Sanger sequencing, we screened XPR1 in 18 unrelated patients with PFBC and no SLC20A2, PDGFB, or PDGFRB mutation. XPR1 variants were tested in an in vitro physiological complementation assay and patient blood cells were assessed ex vivo for phosphate export. We identified a novel c.260T > C, p.(Leu87Pro) XPR1 variant in a 41-year-old man complaining of micrographia and dysarthria and demonstrating mild parkinsonism, cerebellar ataxia and executive dysfunction. Brain (123)I-Ioflupane scintigraphy showed marked dopaminergic neuron loss. Peripheral blood cells from the patient exhibited decreased phosphate export. XPR1 in which we introduced the mutation was not detectable at the cell surface and did not lead to phosphate export. These results confirm that loss of XPR1-mediated phosphate export function causes PFBC, occurring in less than 8 % of cases negative for the other genes, and may be responsible for parkinsonism.

Indexed as

Family HealthAdultBrain DiseasesCalcinosisFemaleGenetic Association StudiesHumansMagnetic Resonance ImagingMaleMutationNortropanesRadionuclide ImagingReceptors, G-Protein-CoupledReceptors, VirusRNA, Small InterferingTransfectionioflupaneNortropanesReceptors, G-Protein-CoupledReceptors, VirusRNA, Small InterferingXenotropic and Polytropic Retrovirus ReceptorXPR1 protein, humanFahr diseaseIdiopathic basal ganglia calcificationPhosphate exportPrimary familial brain calcificationXPR1

Identifiers

PMID27230854
OpenAlexW2395198822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.